Company Filing History:
1 out of 15 
1 out of 1 
1 out of 13 Years Active: 2015-2024
Title: Heribert Bohlen: Innovator in RNA Technology
Introduction
Heribert Bohlen is a distinguished inventor based in Cologne, Germany. He has made significant contributions to the field of biotechnology, particularly in RNA technology. With a total of 3 patents, his work has paved the way for advancements in therapeutic applications.
Latest Patents
Bohlen's latest patents include a "System and method for cell type-specific translation of RNA molecules in eukaryotes." This technology comprises methods and RNA constructs for the targeted translation of a polypeptide of interest in a eukaryotic target cell, with applications in therapeutic clinical settings. Another notable patent is for "Non-invasive, in vitro functional tissue assay systems," which provides functional cell and tissue assay systems based on substrate-integrated multifunctional microelectrode arrays that implement stem cell technology. This system addresses both normal and pathogenic characteristics.
Career Highlights
Throughout his career, Bohlen has worked with several prominent companies, including Mologen AG and SRDT Biotech GmbH. His expertise in biotechnology has been instrumental in the development of innovative solutions in the industry.
Collaborations
Bohlen has collaborated with notable professionals in his field, including Burghardt Wittig and Manuel Schmidt. These partnerships have further enhanced his contributions to biotechnology and innovation.
Conclusion
Heribert Bohlen's work in RNA technology and biotechnology exemplifies the impact of innovation in therapeutic applications. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving clinical outcomes.